
Juan Carlos Turriate Gastulo
Examiner (ID: 2742)
| Most Active Art Unit | 2446 |
| Art Unit(s) | 2446 |
| Total Applications | 424 |
| Issued Applications | 288 |
| Pending Applications | 50 |
| Abandoned Applications | 105 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5638039
[patent_doc_number] => 20060069013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Pharmaceutical preparations comprising acid-stabilised insulin'
[patent_app_type] => utility
[patent_app_number] => 11/227760
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 88262
[patent_no_of_claims] => 129
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069013.pdf
[firstpage_image] =>[orig_patent_app_number] => 11227760
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/227760 | Pharmaceutical preparations comprising acid-stabilised insulin | Sep 11, 2005 | Abandoned |
Array
(
[id] => 5028451
[patent_doc_number] => 20070269898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Amino Acid Sequences Essential to Neuron Specific Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 11/662982
[patent_app_country] => US
[patent_app_date] => 2005-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11662982
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/662982 | Amino Acid Sequences Essential to Neuron Specific Gene Expression | Sep 11, 2005 | Abandoned |
Array
(
[id] => 348956
[patent_doc_number] => 07495072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-24
[patent_title] => 'Process for preparation of mixtures of polypeptides using purified hydrobromic acid'
[patent_app_type] => utility
[patent_app_number] => 11/223072
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6490
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/495/07495072.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223072
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223072 | Process for preparation of mixtures of polypeptides using purified hydrobromic acid | Sep 8, 2005 | Issued |
Array
(
[id] => 5895404
[patent_doc_number] => 20060003943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Protease enzyme inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/221445
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6548
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003943.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221445 | Protease enzyme inhibitors | Sep 7, 2005 | Abandoned |
Array
(
[id] => 5794020
[patent_doc_number] => 20060014701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Novel amide derivatives as growth hormone secretagogues'
[patent_app_type] => utility
[patent_app_number] => 11/218562
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30932
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014701.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218562 | Novel amide derivatives as growth hormone secretagogues | Sep 5, 2005 | Abandoned |
Array
(
[id] => 369884
[patent_doc_number] => 07476657
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-13
[patent_title] => 'Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments'
[patent_app_type] => utility
[patent_app_number] => 11/221348
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 25411
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/476/07476657.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221348
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221348 | Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments | Sep 5, 2005 | Issued |
Array
(
[id] => 5710967
[patent_doc_number] => 20060052312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Paclitaxel hybrid derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/221391
[patent_app_country] => US
[patent_app_date] => 2005-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4581
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11221391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/221391 | Paclitaxel hybrid derivatives | Sep 5, 2005 | Abandoned |
Array
(
[id] => 5710054
[patent_doc_number] => 20060051399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Remedies for liver diseases, hyperlipemia and diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/211688
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7185
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051399.pdf
[firstpage_image] =>[orig_patent_app_number] => 11211688
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/211688 | Remedies for liver diseases, hyperlipemia and diabetes | Aug 25, 2005 | Abandoned |
Array
(
[id] => 4759918
[patent_doc_number] => 20080312144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Peptides for the Treatment of Herpes Virus Infections'
[patent_app_type] => utility
[patent_app_number] => 11/658269
[patent_app_country] => US
[patent_app_date] => 2005-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2247
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312144.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658269
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658269 | Peptides for the treatment of herpes virus infections | Aug 15, 2005 | Issued |
Array
(
[id] => 475310
[patent_doc_number] => 07226906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-05
[patent_title] => 'Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases'
[patent_app_type] => utility
[patent_app_number] => 11/201478
[patent_app_country] => US
[patent_app_date] => 2005-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14972
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/226/07226906.pdf
[firstpage_image] =>[orig_patent_app_number] => 11201478
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/201478 | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | Aug 10, 2005 | Issued |
Array
(
[id] => 5241820
[patent_doc_number] => 20070020312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Method of fabricating a bioactive agent-releasing implantable medical device'
[patent_app_type] => utility
[patent_app_number] => 11/186030
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7853
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11186030
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/186030 | Method of fabricating a bioactive agent-releasing implantable medical device | Jul 19, 2005 | Abandoned |
Array
(
[id] => 5771590
[patent_doc_number] => 20050267041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Tetrapeptide derivative crystals'
[patent_app_type] => utility
[patent_app_number] => 11/180582
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3236
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267041.pdf
[firstpage_image] =>[orig_patent_app_number] => 11180582
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/180582 | Method of making tetrapeptide derivative TZT-1027 crystal | Jul 13, 2005 | Issued |
Array
(
[id] => 5793996
[patent_doc_number] => 20060014677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds'
[patent_app_type] => utility
[patent_app_number] => 11/181580
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9473
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181580
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181580 | Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds | Jul 12, 2005 | Abandoned |
Array
(
[id] => 228989
[patent_doc_number] => 07601802
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-13
[patent_title] => 'Cysteine-containing peptides having antioxidant properties'
[patent_app_type] => utility
[patent_app_number] => 11/177225
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14450
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601802.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177225
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177225 | Cysteine-containing peptides having antioxidant properties | Jul 6, 2005 | Issued |
Array
(
[id] => 5625343
[patent_doc_number] => 20060263848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Cysteine-containing peptides having antioxidant properties'
[patent_app_type] => utility
[patent_app_number] => 11/177237
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14375
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263848.pdf
[firstpage_image] =>[orig_patent_app_number] => 11177237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177237 | Cysteine-containing peptides having antioxidant properties | Jul 6, 2005 | Issued |
Array
(
[id] => 5688927
[patent_doc_number] => 20060287242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions'
[patent_app_type] => utility
[patent_app_number] => 11/170968
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 38964
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287242.pdf
[firstpage_image] =>[orig_patent_app_number] => 11170968
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/170968 | Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions | Jun 29, 2005 | Issued |
Array
(
[id] => 159760
[patent_doc_number] => 07674915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-03-09
[patent_title] => 'Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof'
[patent_app_type] => utility
[patent_app_number] => 11/169677
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10341
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/674/07674915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11169677
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/169677 | Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof | Jun 29, 2005 | Issued |
Array
(
[id] => 210551
[patent_doc_number] => 07625869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-01
[patent_title] => 'Metastin derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/630698
[patent_app_country] => US
[patent_app_date] => 2005-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 98846
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/625/07625869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11630698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/630698 | Metastin derivatives and use thereof | Jun 22, 2005 | Issued |
Array
(
[id] => 369880
[patent_doc_number] => 07476653
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-13
[patent_title] => 'Macrocyclic modulators of the ghrelin receptor'
[patent_app_type] => utility
[patent_app_number] => 11/149731
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 63748
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/476/07476653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149731
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149731 | Macrocyclic modulators of the ghrelin receptor | Jun 9, 2005 | Issued |
Array
(
[id] => 352673
[patent_doc_number] => 07491695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-17
[patent_title] => 'Methods of using macrocyclic modulators of the ghrelin receptor'
[patent_app_type] => utility
[patent_app_number] => 11/149512
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 34
[patent_no_of_words] => 63772
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/491/07491695.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149512
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149512 | Methods of using macrocyclic modulators of the ghrelin receptor | Jun 9, 2005 | Issued |